{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:55:28Z","timestamp":1773021328718,"version":"3.50.1"},"reference-count":56,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health and Medical Research Fund of the Research Fund Secretariat, Food and Health Bureau, HKSAR","award":["04151956"],"award-info":[{"award-number":["04151956"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases and its prevalence is increasing worldwide. It is reported that NAFLD is associated with colorectal polyps. Since identifying NAFLD in its early stages could prevent possible disease progression to cirrhosis and decrease the risk of HCC by early intervention, patients with colorectal polyp may thus be considered a target group for screening NAFLD. This study aimed to investigate the potential of serum microRNAs (miRNAs) in identifying NAFLD for colorectal polyp patients. Serum samples were collected from 141 colorectal polyp patients, of which 38 had NAFLD. The serum level of eight miRNAs was determined by quantitative PCR and delta Ct values of different miRNA pairs which were compared between NAFLD and control groups. A miRNA panel was formulated from candidate miRNA pairs by multiple linear regression model and ROC analysis was performed to evaluate its diagnostic potential for NAFLD. Compared to the control group, the NAFLD group showed significantly lower delta Ct values of miR-18a\/miR-16 (6.141 vs. 7.374, p = 0.009), miR-25-3p\/miR-16 (2.311 vs. 2.978, p = 0.003), miR-18a\/miR-21-5p (4.367 vs. 5.081, p = 0.021) and miR-18a\/miR-92a-3p (8.807 vs. 9.582, p = 0.020). A serum miRNA panel composed of these four miRNA pairs significantly identified NAFLD in colorectal polyp patients with an AUC value of 0.6584 (p = 0.004). The performance of the miRNA panel was further improved to an AUC value of 0.8337 (p &lt; 0.0001) when polyp patients with other concurrent metabolic disorders were removed from the analysis. The serum miRNA panel is a potential diagnostic biomarker for screening NAFLD in colorectal polyp patients. This serum miRNA test could be performed for colorectal polyp patients for early diagnosis and for prevention of the disease from progressing into more advanced stages.<\/jats:p>","DOI":"10.3390\/ijms24109084","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:20:06Z","timestamp":1684812006000},"page":"9084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9010-2654","authenticated-orcid":false,"given":"Lui","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan Wai-Yan","family":"Sin","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Him","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-1059","authenticated-orcid":false,"given":"Wai-Keung","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham Tak-Ka","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-2585","authenticated-orcid":false,"given":"Oswens Siu-Hung","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Lun","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic Chi-Chung","family":"Foo","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43440-019-00020-1","article-title":"New therapeutic strategies in nonalcoholic fatty liver disease: A focus on promising drugs for nonalcoholic steatohepatitis","volume":"72","author":"Pydyn","year":"2020","journal-title":"Pharm. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019\u20132030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3748\/wjg.v21.i14.4103","article-title":"Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question","volume":"21","author":"Streba","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.28524","article-title":"The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health","volume":"64","author":"Rinella","year":"2016","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0036-1584091","article-title":"Colonic Polyps: Diagnosis and Surveillance","volume":"29","author":"Huck","year":"2016","journal-title":"Clin. Colon Rectal Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1038\/s41598-020-63827-6","article-title":"Prevalence and risk factors for colorectal polyps in a Chinese population: A retrospective study","volume":"10","author":"Pan","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Iyer, D.N., Wan, T.M.H., Man, J.H.W., Sin, R.W.Y., Li, X., Lo, O.S.H., Foo, D.C.C., Pang, R.W.C., Law, W.L., and Ng, L. (2020). Small RNA profiling of piRNAs in colorectal cancer identifies consistent overexpression of piR-24000 that correlates clinically with an aggressive disease phenotype. Cancers, 12.","DOI":"10.3390\/cancers12010188"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.mcna.2005.03.001","article-title":"Colorectal cancer and race: Understanding the differences in outcomes between African Americans and whites","volume":"89","author":"Polite","year":"2005","journal-title":"Med. Clin. N. Am."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Siripongpreeda, B., Mahidol, C., Dusitanond, N., Sriprayoon, T., Muyphuag, B., Sricharunrat, T., Teerayatanakul, N., Chaiwong, W., Worasawate, W., and Sattayarungsee, P. (2016). High prevalence of advanced colorectal neoplasia in the Thai population: A prospective screening colonoscopy of 1404 cases. BMC Gastroenterol., 16.","DOI":"10.1186\/s12876-016-0526-0"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/1055-9965.EPI-13-0682","article-title":"The prevalence of colorectal adenomas in asymptomatic Korean men and women","volume":"23","author":"Yang","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3164\/jcbn.18-11","article-title":"Sex differences in associations among metabolic syndrome, obesity, related biomarkers, and colorectal adenomatous polyp risk in a Japanese population","volume":"63","author":"Nakai","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mao, Y., Du, J., Xu, Y., Zhu, Z., and Cao, H. (2019). Helicobacter pylori infection associated with an increased risk of colorectal adenomatous polyps in the Chinese population. BMC Gastroenterol., 19.","DOI":"10.1186\/s12876-018-0918-4"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/2050640618764711","article-title":"Lifestyle factors and risk for colorectal polyps and cancer at index colonoscopy in a FIT-positive screening population","volume":"6","author":"Colussi","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1440-1746.2009.06117.x","article-title":"Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps","volume":"25","author":"Hwang","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_17","first-page":"459","article-title":"Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation","volume":"6","author":"Bhatt","year":"2015","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/jgh.15158","article-title":"High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"35","author":"Chen","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.14218\/JCTH.2019.00010","article-title":"Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population","volume":"7","author":"Li","year":"2019","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/1055-9965.EPI-05-0239","article-title":"Insulin resistance, apoptosis, and colorectal adenoma risk","volume":"14","author":"Keku","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/wasj.2020.71","article-title":"Patients with non-alcoholic fatty liver disease may be a high-risk group for the development of colorectal polyps: A cross-sectional study","volume":"2","author":"Yu","year":"2020","journal-title":"World Acad. Sci. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25168","DOI":"10.3390\/ijms161025168","article-title":"Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease","volume":"16","author":"Valenzuela","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e26835","DOI":"10.1097\/MD.0000000000026835","article-title":"Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease","volume":"100","author":"Kawaguchi","year":"2021","journal-title":"Medicine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1053\/j.gastro.2014.09.047","article-title":"Liver biopsy for the selection of patients with nonalcoholic steatohepatitis for clinical trials","volume":"148","author":"Rowe","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"ref_27","first-page":"98","article-title":"Peripheral blood microRNAs: A novel tool for diagnosing disease?","volume":"1","author":"Wang","year":"2012","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Xin, S., Zhan, Q., Chen, X., Xu, J., and Yu, Y. (2020). Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: A systematic review and meta-analysis. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01334-8"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"736677","DOI":"10.3389\/fcell.2021.736677","article-title":"Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis","volume":"9","author":"Vulf","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1038\/s41598-021-94115-6","article-title":"Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Quintas, G., Caiment, F., Rienda, I., Perez-Rojas, J., Pareja, E., Castell, J.V., and Jover, R. (2022). Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169298"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Landrier, J.F., Derghal, A., and Mounien, L. (2019). MicroRNAs in Obesity and Related Metabolic Disorders. Cells, 8.","DOI":"10.3390\/cells8080859"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3389\/fphys.2018.01879","article-title":"Plasma MicroRNA Pair Panels as Novel Biomarkers for Detection of Early Stage Breast Cancer","volume":"9","author":"Fang","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1073\/pnas.1100048108","article-title":"MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer","volume":"108","author":"Boeri","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hennessey, P.T., Sanford, T., Choudhary, A., Mydlarz, W.W., Brown, D., Adai, A.T., Ochs, M.F., Ahrendt, S.A., Mambo, E., and Califano, J.A. (2012). Serum microRNA biomarkers for detection of non-small cell lung cancer. PloS ONE, 7.","DOI":"10.1371\/annotation\/bda2b1d8-1054-481a-bafd-2bcfa48514e6"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1158\/1078-0432.CCR-12-0035","article-title":"miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts","volume":"18","author":"Matthaei","year":"2012","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/14737159.2014.973858","article-title":"Universal screening test based on analysis of circulating organ-enriched microRNAs: A novel approach to diagnostic screening","volume":"15","author":"Sheinerman","year":"2015","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_38","first-page":"10003","article-title":"Discovery and Verification of Extracellular miRNA Biomarkers for Non-invasive Prediction of Pre-eclampsia in Asymptomatic Women","volume":"1","author":"Srinivasan","year":"2020","journal-title":"Cell Rep. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PloS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"741465","DOI":"10.1155\/2014\/741465","article-title":"MicroRNAs in nonalcoholic fatty liver disease: Novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma","volume":"2014","author":"Gori","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Liang, T., Liu, C., and Ye, Z. (2013). Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs. PloS ONE, 8.","DOI":"10.1371\/journal.pone.0080774"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2020.00007","article-title":"Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100409","DOI":"10.1016\/j.jhepr.2021.100409","article-title":"Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance","volume":"4","author":"Johnson","year":"2022","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41598-019-56630-5","article-title":"MicroRNA profiles in serum samples from Acute-On-Chronic Liver Failure patients and miR-25-3p as a potential biomarker for survival prediction","volume":"10","author":"Cisilotto","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.aohep.2019.12.003","article-title":"Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing","volume":"19","author":"Zhang","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pratama, M.Y., Pascut, D., Tamini, S., Minocci, A., Tiribelli, C., Grugni, G., and Sartorio, A. (2020). Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader-Willi Syndrome and Non-Syndromic Obesity. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041123"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Pescador, N., Perez-Barba, M., Ibarra, J.M., Corbaton, A., Martinez-Larrad, M.T., and Serrano-Rios, M. (2013). Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PloS ONE, 8.","DOI":"10.1371\/journal.pone.0077251"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"814209","DOI":"10.3389\/fendo.2022.814209","article-title":"Non-Alcoholic Fatty Liver Disease in HIV\/HBV Patients\u2014A Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine\/Adipokine Axis Breakdown","volume":"13","author":"Iacob","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Adinolfi, L.E., Rinaldi, L., Guerrera, B., Restivo, L., Marrone, A., Giordano, M., and Zampino, R. (2016). NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060803"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5556354","DOI":"10.1155\/2021\/5556354","article-title":"NAFLD and Infection, a Nuanced Relationship","volume":"2021","author":"Adenote","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1007\/s10620-011-1736-5","article-title":"Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome","volume":"56","author":"Nseir","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_54","first-page":"e20776","article-title":"Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)","volume":"13","author":"Parameswaran","year":"2021","journal-title":"Cureus"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/DMSO.S80364","article-title":"Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: A large cross-sectional and prospective validation study","volume":"8","author":"Lesmana","year":"2015","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/9084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:39:55Z","timestamp":1760125195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/10\/9084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24109084"],"URL":"https:\/\/doi.org\/10.3390\/ijms24109084","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]}}}